Global Norovirus Vaccine Market Growth 2026-2032
The global Norovirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people"s health awareness increases, there will be a huge demand for norovirus vaccines in the future.
LP Information, Inc. (LPI) ' newest research report, the “Norovirus Vaccine Industry Forecast” looks at past sales and reviews total world Norovirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Norovirus Vaccine sales for 2026 through 2032. With Norovirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Norovirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Norovirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Norovirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Norovirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Norovirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Norovirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Norovirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people"s health awareness increases, there will be a huge demand for norovirus vaccines in the future.
LP Information, Inc. (LPI) ' newest research report, the “Norovirus Vaccine Industry Forecast” looks at past sales and reviews total world Norovirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Norovirus Vaccine sales for 2026 through 2032. With Norovirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Norovirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Norovirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Norovirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Norovirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Norovirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Norovirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Norovirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bivalent
- Quadrivalent
- Hexavalent
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hillevax
- Vaxart
- Moderna
- UMN Pharma
- Daiichi Sankyo
- Kanghua Biology
- Beijing Institute of Biological Products
- Zhifei Bio
- China Biotechnology Co., Ltd.
- North China Pharmaceutical
- What is the 10-year outlook for the global Norovirus Vaccine market?
- What factors are driving Norovirus Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Norovirus Vaccine market opportunities vary by end market size?
- How does Norovirus Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Norovirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Norovirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Norovirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Norovirus Vaccine Segment by Type
2.2.1 Bivalent
2.2.2 Quadrivalent
2.2.3 Hexavalent
2.2.4 Norovirus Vaccine Sales by Type
2.2.4.1 Global Norovirus Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Norovirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Norovirus Vaccine Sale Price by Type (2021-2026)
2.3 Norovirus Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Norovirus Vaccine Sales by Application
2.3.4.1 Global Norovirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Norovirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Norovirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Norovirus Vaccine Breakdown Data by Company
3.1.1 Global Norovirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Norovirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Norovirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Norovirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Norovirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Norovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Norovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Norovirus Vaccine Product Location Distribution
3.4.2 Players Norovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NOROVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Norovirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Norovirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Norovirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Norovirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Norovirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Norovirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Norovirus Vaccine Sales Growth
4.4 APAC Norovirus Vaccine Sales Growth
4.5 Europe Norovirus Vaccine Sales Growth
4.6 Middle East & Africa Norovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Norovirus Vaccine Sales by Country
5.1.1 Americas Norovirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Norovirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Norovirus Vaccine Sales by Type (2021-2026)
5.3 Americas Norovirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Norovirus Vaccine Sales by Region
6.1.1 APAC Norovirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Norovirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Norovirus Vaccine Sales by Type (2021-2026)
6.3 APAC Norovirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Norovirus Vaccine by Country
7.1.1 Europe Norovirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Norovirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Norovirus Vaccine Sales by Type (2021-2026)
7.3 Europe Norovirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Norovirus Vaccine by Country
8.1.1 Middle East & Africa Norovirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Norovirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Norovirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Norovirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Norovirus Vaccine
10.3 Manufacturing Process Analysis of Norovirus Vaccine
10.4 Industry Chain Structure of Norovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Norovirus Vaccine Distributors
11.3 Norovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR NOROVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Norovirus Vaccine Market Size Forecast by Region
12.1.1 Global Norovirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Norovirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Norovirus Vaccine Forecast by Type (2027-2032)
12.7 Global Norovirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hillevax
13.1.1 Hillevax Company Information
13.1.2 Hillevax Norovirus Vaccine Product Portfolios and Specifications
13.1.3 Hillevax Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hillevax Main Business Overview
13.1.5 Hillevax Latest Developments
13.2 Vaxart
13.2.1 Vaxart Company Information
13.2.2 Vaxart Norovirus Vaccine Product Portfolios and Specifications
13.2.3 Vaxart Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Vaxart Main Business Overview
13.2.5 Vaxart Latest Developments
13.3 Moderna
13.3.1 Moderna Company Information
13.3.2 Moderna Norovirus Vaccine Product Portfolios and Specifications
13.3.3 Moderna Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Moderna Main Business Overview
13.3.5 Moderna Latest Developments
13.4 UMN Pharma
13.4.1 UMN Pharma Company Information
13.4.2 UMN Pharma Norovirus Vaccine Product Portfolios and Specifications
13.4.3 UMN Pharma Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 UMN Pharma Main Business Overview
13.4.5 UMN Pharma Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Norovirus Vaccine Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Kanghua Biology
13.6.1 Kanghua Biology Company Information
13.6.2 Kanghua Biology Norovirus Vaccine Product Portfolios and Specifications
13.6.3 Kanghua Biology Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kanghua Biology Main Business Overview
13.6.5 Kanghua Biology Latest Developments
13.7 Beijing Institute of Biological Products
13.7.1 Beijing Institute of Biological Products Company Information
13.7.2 Beijing Institute of Biological Products Norovirus Vaccine Product Portfolios and Specifications
13.7.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Beijing Institute of Biological Products Main Business Overview
13.7.5 Beijing Institute of Biological Products Latest Developments
13.8 Zhifei Bio
13.8.1 Zhifei Bio Company Information
13.8.2 Zhifei Bio Norovirus Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Bio Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhifei Bio Main Business Overview
13.8.5 Zhifei Bio Latest Developments
13.9 China Biotechnology Co., Ltd.
13.9.1 China Biotechnology Co., Ltd. Company Information
13.9.2 China Biotechnology Co., Ltd. Norovirus Vaccine Product Portfolios and Specifications
13.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 China Biotechnology Co., Ltd. Main Business Overview
13.9.5 China Biotechnology Co., Ltd. Latest Developments
13.10 North China Pharmaceutical
13.10.1 North China Pharmaceutical Company Information
13.10.2 North China Pharmaceutical Norovirus Vaccine Product Portfolios and Specifications
13.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 North China Pharmaceutical Main Business Overview
13.10.5 North China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Norovirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Norovirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Norovirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Norovirus Vaccine Segment by Type
2.2.1 Bivalent
2.2.2 Quadrivalent
2.2.3 Hexavalent
2.2.4 Norovirus Vaccine Sales by Type
2.2.4.1 Global Norovirus Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Norovirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Norovirus Vaccine Sale Price by Type (2021-2026)
2.3 Norovirus Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Norovirus Vaccine Sales by Application
2.3.4.1 Global Norovirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Norovirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Norovirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Norovirus Vaccine Breakdown Data by Company
3.1.1 Global Norovirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Norovirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Norovirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Norovirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Norovirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Norovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Norovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Norovirus Vaccine Product Location Distribution
3.4.2 Players Norovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NOROVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Norovirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Norovirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Norovirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Norovirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Norovirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Norovirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Norovirus Vaccine Sales Growth
4.4 APAC Norovirus Vaccine Sales Growth
4.5 Europe Norovirus Vaccine Sales Growth
4.6 Middle East & Africa Norovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Norovirus Vaccine Sales by Country
5.1.1 Americas Norovirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Norovirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Norovirus Vaccine Sales by Type (2021-2026)
5.3 Americas Norovirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Norovirus Vaccine Sales by Region
6.1.1 APAC Norovirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Norovirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Norovirus Vaccine Sales by Type (2021-2026)
6.3 APAC Norovirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Norovirus Vaccine by Country
7.1.1 Europe Norovirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Norovirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Norovirus Vaccine Sales by Type (2021-2026)
7.3 Europe Norovirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Norovirus Vaccine by Country
8.1.1 Middle East & Africa Norovirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Norovirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Norovirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Norovirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Norovirus Vaccine
10.3 Manufacturing Process Analysis of Norovirus Vaccine
10.4 Industry Chain Structure of Norovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Norovirus Vaccine Distributors
11.3 Norovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR NOROVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Norovirus Vaccine Market Size Forecast by Region
12.1.1 Global Norovirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Norovirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Norovirus Vaccine Forecast by Type (2027-2032)
12.7 Global Norovirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hillevax
13.1.1 Hillevax Company Information
13.1.2 Hillevax Norovirus Vaccine Product Portfolios and Specifications
13.1.3 Hillevax Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hillevax Main Business Overview
13.1.5 Hillevax Latest Developments
13.2 Vaxart
13.2.1 Vaxart Company Information
13.2.2 Vaxart Norovirus Vaccine Product Portfolios and Specifications
13.2.3 Vaxart Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Vaxart Main Business Overview
13.2.5 Vaxart Latest Developments
13.3 Moderna
13.3.1 Moderna Company Information
13.3.2 Moderna Norovirus Vaccine Product Portfolios and Specifications
13.3.3 Moderna Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Moderna Main Business Overview
13.3.5 Moderna Latest Developments
13.4 UMN Pharma
13.4.1 UMN Pharma Company Information
13.4.2 UMN Pharma Norovirus Vaccine Product Portfolios and Specifications
13.4.3 UMN Pharma Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 UMN Pharma Main Business Overview
13.4.5 UMN Pharma Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Norovirus Vaccine Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Kanghua Biology
13.6.1 Kanghua Biology Company Information
13.6.2 Kanghua Biology Norovirus Vaccine Product Portfolios and Specifications
13.6.3 Kanghua Biology Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kanghua Biology Main Business Overview
13.6.5 Kanghua Biology Latest Developments
13.7 Beijing Institute of Biological Products
13.7.1 Beijing Institute of Biological Products Company Information
13.7.2 Beijing Institute of Biological Products Norovirus Vaccine Product Portfolios and Specifications
13.7.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Beijing Institute of Biological Products Main Business Overview
13.7.5 Beijing Institute of Biological Products Latest Developments
13.8 Zhifei Bio
13.8.1 Zhifei Bio Company Information
13.8.2 Zhifei Bio Norovirus Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Bio Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhifei Bio Main Business Overview
13.8.5 Zhifei Bio Latest Developments
13.9 China Biotechnology Co., Ltd.
13.9.1 China Biotechnology Co., Ltd. Company Information
13.9.2 China Biotechnology Co., Ltd. Norovirus Vaccine Product Portfolios and Specifications
13.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 China Biotechnology Co., Ltd. Main Business Overview
13.9.5 China Biotechnology Co., Ltd. Latest Developments
13.10 North China Pharmaceutical
13.10.1 North China Pharmaceutical Company Information
13.10.2 North China Pharmaceutical Norovirus Vaccine Product Portfolios and Specifications
13.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 North China Pharmaceutical Main Business Overview
13.10.5 North China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Norovirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Norovirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bivalent
Table 4. Major Players of Quadrivalent
Table 5. Major Players of Hexavalent
Table 6. Global Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Norovirus Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Norovirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Norovirus Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Norovirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Norovirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Norovirus Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Norovirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Norovirus Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Norovirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Norovirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Norovirus Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Norovirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Norovirus Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Norovirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Norovirus Vaccine Producing Area Distribution and Sales Area
Table 22. Players Norovirus Vaccine Products Offered
Table 23. Norovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Norovirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Norovirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Norovirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Norovirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Norovirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Norovirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Norovirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Norovirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Norovirus Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Norovirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Norovirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Norovirus Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Norovirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Norovirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Norovirus Vaccine
Table 53. Key Market Challenges & Risks of Norovirus Vaccine
Table 54. Key Industry Trends of Norovirus Vaccine
Table 55. Norovirus Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Norovirus Vaccine Distributors List
Table 58. Norovirus Vaccine Customer List
Table 59. Global Norovirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Norovirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Norovirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Norovirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Norovirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Norovirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Norovirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Norovirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Norovirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Norovirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Norovirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Hillevax Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Hillevax Norovirus Vaccine Product Portfolios and Specifications
Table 75. Hillevax Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Hillevax Main Business
Table 77. Hillevax Latest Developments
Table 78. Vaxart Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Vaxart Norovirus Vaccine Product Portfolios and Specifications
Table 80. Vaxart Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Vaxart Main Business
Table 82. Vaxart Latest Developments
Table 83. Moderna Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Moderna Norovirus Vaccine Product Portfolios and Specifications
Table 85. Moderna Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Moderna Main Business
Table 87. Moderna Latest Developments
Table 88. UMN Pharma Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. UMN Pharma Norovirus Vaccine Product Portfolios and Specifications
Table 90. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. UMN Pharma Main Business
Table 92. UMN Pharma Latest Developments
Table 93. Daiichi Sankyo Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Norovirus Vaccine Product Portfolios and Specifications
Table 95. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. Kanghua Biology Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Kanghua Biology Norovirus Vaccine Product Portfolios and Specifications
Table 100. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Kanghua Biology Main Business
Table 102. Kanghua Biology Latest Developments
Table 103. Beijing Institute of Biological Products Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Institute of Biological Products Norovirus Vaccine Product Portfolios and Specifications
Table 105. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Beijing Institute of Biological Products Main Business
Table 107. Beijing Institute of Biological Products Latest Developments
Table 108. Zhifei Bio Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhifei Bio Norovirus Vaccine Product Portfolios and Specifications
Table 110. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zhifei Bio Main Business
Table 112. Zhifei Bio Latest Developments
Table 113. China Biotechnology Co., Ltd. Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. China Biotechnology Co., Ltd. Norovirus Vaccine Product Portfolios and Specifications
Table 115. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. China Biotechnology Co., Ltd. Main Business
Table 117. China Biotechnology Co., Ltd. Latest Developments
Table 118. North China Pharmaceutical Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. North China Pharmaceutical Norovirus Vaccine Product Portfolios and Specifications
Table 120. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. North China Pharmaceutical Main Business
Table 122. North China Pharmaceutical Latest Developments
Table 1. Norovirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Norovirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bivalent
Table 4. Major Players of Quadrivalent
Table 5. Major Players of Hexavalent
Table 6. Global Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Norovirus Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Norovirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Norovirus Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Norovirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Norovirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Norovirus Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Norovirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Norovirus Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Norovirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Norovirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Norovirus Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Norovirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Norovirus Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Norovirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Norovirus Vaccine Producing Area Distribution and Sales Area
Table 22. Players Norovirus Vaccine Products Offered
Table 23. Norovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Norovirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Norovirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Norovirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Norovirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Norovirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Norovirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Norovirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Norovirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Norovirus Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Norovirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Norovirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Norovirus Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Norovirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Norovirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Norovirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Norovirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Norovirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Norovirus Vaccine
Table 53. Key Market Challenges & Risks of Norovirus Vaccine
Table 54. Key Industry Trends of Norovirus Vaccine
Table 55. Norovirus Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Norovirus Vaccine Distributors List
Table 58. Norovirus Vaccine Customer List
Table 59. Global Norovirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Norovirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Norovirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Norovirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Norovirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Norovirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Norovirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Norovirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Norovirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Norovirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Norovirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Norovirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Hillevax Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Hillevax Norovirus Vaccine Product Portfolios and Specifications
Table 75. Hillevax Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Hillevax Main Business
Table 77. Hillevax Latest Developments
Table 78. Vaxart Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Vaxart Norovirus Vaccine Product Portfolios and Specifications
Table 80. Vaxart Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Vaxart Main Business
Table 82. Vaxart Latest Developments
Table 83. Moderna Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Moderna Norovirus Vaccine Product Portfolios and Specifications
Table 85. Moderna Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Moderna Main Business
Table 87. Moderna Latest Developments
Table 88. UMN Pharma Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. UMN Pharma Norovirus Vaccine Product Portfolios and Specifications
Table 90. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. UMN Pharma Main Business
Table 92. UMN Pharma Latest Developments
Table 93. Daiichi Sankyo Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Norovirus Vaccine Product Portfolios and Specifications
Table 95. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. Kanghua Biology Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Kanghua Biology Norovirus Vaccine Product Portfolios and Specifications
Table 100. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Kanghua Biology Main Business
Table 102. Kanghua Biology Latest Developments
Table 103. Beijing Institute of Biological Products Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Institute of Biological Products Norovirus Vaccine Product Portfolios and Specifications
Table 105. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Beijing Institute of Biological Products Main Business
Table 107. Beijing Institute of Biological Products Latest Developments
Table 108. Zhifei Bio Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhifei Bio Norovirus Vaccine Product Portfolios and Specifications
Table 110. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zhifei Bio Main Business
Table 112. Zhifei Bio Latest Developments
Table 113. China Biotechnology Co., Ltd. Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. China Biotechnology Co., Ltd. Norovirus Vaccine Product Portfolios and Specifications
Table 115. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. China Biotechnology Co., Ltd. Main Business
Table 117. China Biotechnology Co., Ltd. Latest Developments
Table 118. North China Pharmaceutical Basic Information, Norovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. North China Pharmaceutical Norovirus Vaccine Product Portfolios and Specifications
Table 120. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. North China Pharmaceutical Main Business
Table 122. North China Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Norovirus Vaccine
Figure 2. Norovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Norovirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Norovirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Norovirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Norovirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Norovirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bivalent
Figure 12. Product Picture of Quadrivalent
Figure 13. Product Picture of Hexavalent
Figure 14. Global Norovirus Vaccine Sales Market Share by Type in 2026
Figure 15. Global Norovirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Norovirus Vaccine Consumed in Hospital
Figure 17. Global Norovirus Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 18. Norovirus Vaccine Consumed in Clinic
Figure 19. Global Norovirus Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 20. Norovirus Vaccine Consumed in Others
Figure 21. Global Norovirus Vaccine Market: Others (2021-2026) & (K Units)
Figure 22. Global Norovirus Vaccine Sale Market Share by Application (2025)
Figure 23. Global Norovirus Vaccine Revenue Market Share by Application in 2026
Figure 24. Norovirus Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global Norovirus Vaccine Sales Market Share by Company in 2026
Figure 26. Norovirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Norovirus Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Norovirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Norovirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Norovirus Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Norovirus Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Norovirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Norovirus Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Norovirus Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Norovirus Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Norovirus Vaccine
Figure 76. Industry Chain Structure of Norovirus Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Norovirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Norovirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Norovirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Norovirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Norovirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Norovirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Norovirus Vaccine
Figure 2. Norovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Norovirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Norovirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Norovirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Norovirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Norovirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bivalent
Figure 12. Product Picture of Quadrivalent
Figure 13. Product Picture of Hexavalent
Figure 14. Global Norovirus Vaccine Sales Market Share by Type in 2026
Figure 15. Global Norovirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Norovirus Vaccine Consumed in Hospital
Figure 17. Global Norovirus Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 18. Norovirus Vaccine Consumed in Clinic
Figure 19. Global Norovirus Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 20. Norovirus Vaccine Consumed in Others
Figure 21. Global Norovirus Vaccine Market: Others (2021-2026) & (K Units)
Figure 22. Global Norovirus Vaccine Sale Market Share by Application (2025)
Figure 23. Global Norovirus Vaccine Revenue Market Share by Application in 2026
Figure 24. Norovirus Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global Norovirus Vaccine Sales Market Share by Company in 2026
Figure 26. Norovirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Norovirus Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Norovirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Norovirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Norovirus Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Norovirus Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Norovirus Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Norovirus Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Norovirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Norovirus Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Norovirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Norovirus Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Norovirus Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Norovirus Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Norovirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Norovirus Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Norovirus Vaccine
Figure 76. Industry Chain Structure of Norovirus Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Norovirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Norovirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Norovirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Norovirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Norovirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Norovirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
